Non-small Cell Lung Cancer Stage III
1 competing product in clinical development for Non-small Cell Lung Cancer Stage III.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lazertinib | Yuhan | Phase 2 | UNKNOWN | 31 |
1 competing product in clinical development for Non-small Cell Lung Cancer Stage III.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lazertinib | Yuhan | Phase 2 | UNKNOWN | 31 |